Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.43 |
| ▸ | JAK3 | P52333 | 1/20 | 0.43 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 3/20 | 0.37 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RXRA | P19793 | 1/20 | 0.36 |
| ▸ | RXRB | P28702 | 1/20 | 0.36 |
| ▸ | RXRG | P48443 | 1/20 | 0.36 |
| ▸ | FBP1 | P09467 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6856533 | 0.95 | CES2 (0.41) | CES2RPS6KA3JAK3KIF11ALDH1A1 | |
| SCHEMBL18002229 | 0.91 | AHR (0.41) | CES2RPS6KA3JAK3KIF11FBP1 | |
| SCHEMBL30070463 | 0.86 | KIF11 (0.38) | CES2RPS6KA3JAK3KIF11ALDH1A1 | |
| SCHEMBL478113 | 0.86 | KIF11 (0.38) | CES2RPS6KA3JAK3KIF11ALDH1A1 | |
| SCHEMBL15456420 | 0.85 | CES2 (0.41) | CES2RPS6KA3JAK3MAPT | |
| SCHEMBL18002364 | 0.85 | DAO (0.44) | CES2RPS6KA3JAK3IDO1TDO2 | |
| SCHEMBL344606 | 0.84 | NOTUM (0.43) | CES2RPS6KA3JAK3KIF11IDO1 | |
| SCHEMBL29769014 | 0.84 | AHR (0.48) | CES2RPS6KA3JAK3KIF11ALDH1A1 | |
| SCHEMBL13616882 | 0.84 | PTGS1 (0.48) | CES2RPS6KA3JAK3IDO1ALDH1A1 | |
| SCHEMBL2474610 | 0.84 | NFE2L2 (0.41) | CES2RPS6KA3JAK3KIF11MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122011612-A | Chlorosulfonated polyethylene rubber with high heat resistance and preparation method thereof | 江西华琪合成橡胶有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-120118070-A | Molecular chaperone HSP 70-mediated EML4-ALK targeted degradation agent, preparation method and application | 浙江大学 | 2025-06-10 | — | — | CN | claimed |
| CN-117143598-B | High-entropy carbon quantum dot nanomaterial and preparation method and application thereof | 中南大学 | 2024-11-08 | — | — | CN | claimed |
| CN-118580159-A | Synthesis method of nitrogen heterocyclic aromatic hydrocarbon modified beta-amino acid ester | 国科大杭州高等研究院 | 2024-09-03 | — | — | CN | claimed |
| CN-118459422-A | Thiazole thiazolinone compound containing multiple halogen atoms and preparation method thereof | 南京工业大学 | 2024-08-09 | — | — | CN | claimed |
| CN-118459420-A | Thiazolinone compound containing multiple halogen atoms and preparation method thereof | 南京工业大学 | 2024-08-09 | — | — | CN | claimed |
| CN-117229707-A | High-strength wear-resistant aluminum veneer and preparation method thereof | 兴恒泰有限公司 | 2023-12-15 | — | — | CN | claimed |
| CN-117143598-A | High-entropy carbon quantum dot nanomaterial and preparation method and application thereof | 中南大学 | 2023-12-01 | — | — | CN | claimed |
| CN-116396475-A | Nano-carrier based on fluorinated polymer and preparation method and application thereof | 浙江大学 | 2023-07-07 | — | — | CN | claimed |
| US-20230215723-A1 | METHODS OF MANUFACTURING INTEGRATED CIRCUIT DEVICES USING CARBONYL COMPOUNDS | ADEKA CORPORATION (JP) | 2023-07-06 | — | — | US | claimed |
| US-6150378-A | 1-((1-HALO-SUBSTITUTEDBENZOYLAMINO)-2-PHENYLETHYL)-CARBONYL -CARBONYLAMINO),2-PHENYL OR PYRID-2-YLSULFAMIDO)ETHANE DERIVATIVES; MUSCULAR DYSTROPHY, NEURODEGENERATION, STROKE, ALZHEIMER'S, AMYOTROPHY, MOTOR NEURON DAMAGE, CNS INJURY | CEPHALON, INC. (US) | 2000-11-21 | — | — | US | claimed |
| WO-2000012074-A2 | USE OF PIPERIDINES AND/OR PIPERAZINES AS INHIBITORS OF P38-ALPHA KINASE | SCIOS INC. (US) | 2000-03-09 | — | — | WO | claimed |
| EP-0983507-A1 | TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES | Trega Biosciences, Inc. (US) | 2000-03-08 | — | — | EP | claimed |
| EP-0977989-A1 | 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 2000-02-09 | — | — | EP | claimed |
| US-5935951-A | ANTAGONIST AGAINST SUBSTANCE P | NOVARTIS FINANCE CORPORATION (US) | 1999-08-10 | — | — | US | claimed |
| WO-1998034115-A1 | 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| WO-1998034111-A1 | TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES | TREGA BIOSCIENCES, INC. (US) | 1998-08-06 | — | — | WO | claimed |
| WO-1997045119-A1 | USE OF SUBSTANCE P ANTAGONISTS FOR TREATING SOCIAL PHOBIA | NOVARTIS AG (CH) | 1997-12-04 | — | — | WO | claimed |
| EP-0783490-A1 | 1-ACYL-4-ALIPHATYLAMINOPIPERIDINE COMPOUNDS | Novartis AG (CH) | 1997-07-16 | — | — | EP | claimed |
| WO-1996010562-A1 | 1-ACYL-4-ALIPHATYLAMINOPIPERIDINE COMPOUNDS | NOVARTIS AG (CH) | 1996-04-11 | — | — | WO | claimed |